Allmed Medical Products Co.,Ltd (SHE:002950)
China flag China · Delayed Price · Currency is CNY
8.03
0.00 (0.00%)
Nov 17, 2026, 3:04 PM CST

SHE:002950 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,9173,6323,2932,7074,1952,888
Other Revenue
40.0340.0333.1249.415.7837.44
3,9573,6723,3262,7574,2112,926
Revenue Growth
13.95%10.38%20.66%-34.53%43.92%-23.70%
Cost of Revenue
2,7852,6062,3982,0992,8122,053
Gross Profit
1,1721,065928.04657.931,399872.17
Selling, General & Admin
435.54366.61374.65386.38446.53367.52
Research & Development
118.46104.05106.3777.37107.7494.58
Other Operating Expenses
-4.117.8110.4913.8226.4719.13
Operating Expenses
558.66492.51494.41478.51582.45484.52
Operating Income
613.09572.63433.64179.42816.21387.65
Interest Expense
-25.42-17.67-25.53-31.87-35.47-17.18
Interest & Investment Income
37.816.677.161.873.0939.97
Currency Exchange Gain (Loss)
-11.62-11.6217.15-8.57-140.6333.41
Other Non Operating Income (Expenses)
-65.1-1.9-1.27-2-6.3-6.34
EBT Excluding Unusual Items
548.75558.11431.15138.85636.9437.51
Gain (Loss) on Sale of Investments
-271.35-268.88-23.28-6.88-160.196.13
Gain (Loss) on Sale of Assets
-30.670.7728.79-0.073.51.94
Asset Writedown
-3.11-11.5-9.140.5-16.8-0.12
Other Unusual Items
25.1230.5326.8736.6521.4959.79
Pretax Income
268.74309.02454.39169.04484.9505.49
Income Tax Expense
27.6651.8785.5964.8380.2673.53
Earnings From Continuing Operations
241.08257.15368.8104.22404.64431.96
Minority Interest in Earnings
-19.79-8.26-0.126.182.15-0.75
Net Income
221.29248.88368.68110.4406.79431.21
Net Income to Common
221.29248.88368.68110.4406.79431.21
Net Income Growth
-51.08%-32.49%233.95%-72.86%-5.66%-62.75%
Shares Outstanding (Basic)
606619625633633632
Shares Outstanding (Diluted)
606619625633633632
Shares Change
-3.62%-0.99%-1.33%0.02%0.17%-0.05%
EPS (Basic)
0.360.400.590.170.640.68
EPS (Diluted)
0.360.400.590.170.640.68
EPS Growth
-49.24%-31.82%238.44%-72.87%-5.82%-62.73%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-187.05456.81554.64137.02751.6884.16
Free Cash Flow Per Share
-0.310.740.890.221.190.13
Dividend Per Share
0.1460.1460.0600.0270.0600.210
Dividend Growth
143.33%143.33%122.22%-55.00%-71.43%-76.14%
Gross Margin
29.61%29.01%27.90%23.87%33.22%29.81%
Operating Margin
15.49%15.60%13.04%6.51%19.38%13.25%
Profit Margin
5.59%6.78%11.08%4.00%9.66%14.74%
Free Cash Flow Margin
-4.73%12.44%16.68%4.97%17.85%2.88%
EBITDA
847.79803658.24403.431,008532.77
EBITDA Margin
21.42%21.87%19.79%14.64%23.95%18.21%
D&A For EBITDA
234.7230.37224.6224192.2145.12
EBIT
613.09572.63433.64179.42816.21387.65
EBIT Margin
15.49%15.60%13.04%6.51%19.38%13.25%
Effective Tax Rate
10.29%16.79%18.84%38.35%16.55%14.55%
Revenue as Reported
3,9573,6723,3262,7574,2112,926
Advertising Expenses
-22.4717.9715.98-27.1